Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.”
A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.
Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.
A new analysis in JACR estimates that spotting the signs of a previously undetected stroke could benefit up to 200,000 people in the United States every year.
President-elect Donald Trump announced the nomination of former "Dr. Oz Show" star Mehmet Oz just days after appointing Robert F. Kennedy Jr. as secretary of health.
Rechargeable batteries used on CADD-Solis Li-ion infusion systems may short out if damaged, possibly causing the case to melt. No injuries have been reported.
Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.”
A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.